HEALTH

Aisle7 promotes health, wellness with online widget gallery

BY Michael Johnsen

PORTLAND, Ore. Aisle7 on Thursday announced the launch of its Aisle7 online widget gallery, home to plug-and-play mini apps that easily can be placed on a website to inform shoppers of the latest health recommendations, provide shopping ideas and recommend products for health-and-wellness goals. The widgets also provide website content producers a cost-effective solution that automatically updates a page with the latest wellness content without extra development overhead.

 

“As part of our LiveRight with ShopRite program, we have partnered with Aisle7 to deliver relevant and credible health-and-wellness content and health widgets for our Shoprite.com customers,” stated Cheryl Williams, VP marketing for Wakefern Food Corp. “This helps our customers make informed decisions about health-and-wellness choices for their lifestyle, and provides our customers with a valuable service.”

 

 

The new widgets come in the following formats:

  • Slideshows — media-rich presentations that engage shoppers with tips and recommendations for top health concerns and goals; 
  • Product finders — interactive consumer decision tools that connect shoppers with self-care products and improve site conversion; and
  • Favorites and indexes — multitabbed content containers that feature the most important wellness recommendations for a health goal.

 

 

The widget gallery also includes widgets for campaigns, quick tips and news providing retailers numerous options to build customized landing pages that support a marketing program. Trend-inspired topics, such as diabetes prevention, antiaging and healthy eating, are available in multiple widget types to support an existing page or build a new page from scratch to target a specific audience.

 

 

“We’re excited about the new opportunities the widget gallery provides our customers to target their shoppers on the latest wellness topics,” stated Jeffrey Beyer, CEO of Aisle7. “The Aisle7 online widget gallery allows our customers to both drive higher levels of engagement and improve site conversion for their online wellness marketing programs.”

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Rite Aid posts same-store sales decline

BY Michael Johnsen

CAMP HILL, Pa. Rite Aid on Thursday posted a same-store sales decrease of 1.7% for the four weeks ended Oct. 23, representing a front-end comparable sales decline of 1.3% and a 1.8% drop in same-store pharmacy sales.

Prescriptions filled at comparable stores decreased 1.9% over the prior-year period.

Both front-end and pharmacy same-store sales were negatively impacted by a significantly weaker cough, cold and flu season compared with the same period last year, when news of an H1N1 pandemic was dominating the airwaves.

Total drug store sales for the four-week period decreased 2.7% to $1.9 billion. Prescription revenue accounted for 68.5% of drug store sales, and third-party prescription revenue represented 96.2% of pharmacy sales.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

GSK Consumer Healthcare applauds FDA’s workshop on NRT products

BY Michael Johnsen

PARSIPPANY, N.J. GlaxoSmithKline Consumer Healthcare on Thursday commended the Food and Drug Administration for holding a scientific workshop this week that focused on the risks and benefits associated with the long-term use of nicotine-replacement therapy products.

 

GSK, the manufacturer of smoking-cessation products NicoDerm and Nicorette, suggested the workshop is a first step in supporting language in the 2009 Family Smoking Prevention and Tobacco Control Act, which called upon the FDA to "consider approving the extended use of nicotine-replacement products — such as nicotine patches, nicotine gum and nicotine lozenge — for the treatment of tobacco dependence."

 

 

As a result of the FDA’s review of long-term use, GSK has submitted a statement into the FDA public docket on its position regarding the long-term use of NRT. GSK believes that using NRT products to quit smoking is far safer than continuing to smoke. NRT products offer a step-down therapy that doubles a smoker’s chances of quitting versus attempting to quit smoking “cold turkey.” Additionally, several other countries already encourage the use of NRT products for longer durations to keep people tobacco-free.

 

 

Smoking is the No. 1 preventable cause of disease and death in the United States. More than 46 million Americans smoke. Research indicated about 70% of smokers want to quit at any given time, but the success rates remain suboptimal. Tobacco use causes more than 400,000 deaths in the United States each year, and approximately 8.6 million Americans have chronic illnesses related to smoking.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?